Company: ATRA
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-059322
Chunk: 35

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 35
---
 proxy and entitled to vote on the matter at the annual meeting. Unless the Board decides to modify its policy regarding the frequency of soliciting advisory votes on the compensation of the Company’s named executives, the next scheduled say-on-pay vote will be at the 2026 Annual Meeting of Stockholders.

<div align='center'>The Board Of Directors Recommends

A Vote In Favor Of Proposal 2

21

PROPOSAL 3

ADVISORY VOTE ON THE FREQUENCY OF

STOCKHOLDER ADVISORY VOTES ON EXECUTIVE COMPENSATION</div>

Section 14A of the Exchange Act requires that we hold an advisory vote at least once every six calendar years on the frequency of future advisory votes regarding the compensation of our named executive officers. Accordingly, stockholders are asked to vote, on an advisory basis, whether the frequency of future advisory votes on the compensation of the Company’s named executive officers should be held every year, every other year, or every three years. Alternatively, stockholders may abstain from casting a vote. For the reasons described below, the Board recommends that the stockholders vote for a frequency of every year.

When we conducted our last vote at our 2019 Annual Meeting of Stockholders, our stockholders expressed a strong preference to conduct advisory votes on an annual basis. Consistent with that preference, since that time, we have continued to hold annual advisory votes on the compensation of our named executive officers. Over the past six years, the Board has not found any basis to believe that the previously-expressed stockholder preference should not continue to govern and notes that annual advisory votes continue as the most prevalent market practice and are consistent with most institutional investor policies. While our executive compensation programs are designed to promote the creation of stockholder value over the long term, the Board believes that an annual advisory vote on executive compensation provides us with more direct and immediate feedback on our compensation disclosures and investor views about our executive compensation philosophy, policies, and practices. We also believe that an annual advisory vote on executive compensation is consistent with our practice of seeking input and engaging with our stockholders to further understand their perspectives.

While the Board believes that its recommendation is appropriate at this time, the stockholders are not voting to approve or disapprove that recommendation, but are instead asked to vote, on an advisory basis, on whether the advisory vote on the approval of the Company’s executive officer compensation practices should be held every year, every other year, or every three years. The option among those choices that receives the votes of